Intellectual Property

Book by the South Centre, 2013

Derechos de Propiedad Intelectual, Investigación y Desarrollo, Derechos Humanos y Acceso a Medicamentos: Bibliografía Seleccionada y Anotada

Descripción:

El Centro del Sur ha preparado esta bibliografía seleccionada y anotada para asistir a los países en desarrollo en la implementación de políticas y reglamentaciones en materia de PI de manera coherente con los objetivos de desarrollo y los principios de salud pública. El creciente volumen de literatura que se está produciendo en torno al tema de PI, I+D, derechos humanos y acceso a medicamentos en los últimos cinco años puede ayudar a los países a encontrar las oportunidades y el espacio de maniobra para proteger a los ciudadanos de los países en desarrollo del medio insano que han generado las nuevas normas del comercio internacional.

Autores: Germán Velásquez, Carlos M. Correa, Xavier Seuba

(more…)

Book by the South Centre, 2013

Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing

 

Bk_2013_Pharmaceutical innovation_EN_001About the book: This book examines patent trends and the use of compulsory licenses relating to pharmaceuticals in five developing countries: Argentina, Brazil, Colombia, India and South Africa. It finds a number of common features and problems, and shows how the application of rigorous standards of patentability may contribute to protect public health by promoting local production and competition.

Editor: Carlos M. Correa is the Special Advisor on Intellectual Property and Trade of the South Centre and Director of the Center for Interdisciplinary Studies on Industrial Property at the Law Faculty, University of Buenos Aires.

Download Book

Save

Save

Save

Book by the South Centre and WHO, 2013

Intellectual Property and Access to Medicines

 

Bk_2013_IP and Access to Medicines_EN_001

About the book: This volume contains a selection of papers used in the course “Towards an Intellectual Property Regime that Protects Public Health”. They explore the principal issues in intellectual property as it relates to public health. They are comprehensive, though not exhaustive, as the field is a constantly evolving one.

This publication is intended to facilitate the conducting of further courses on the implication of intellectual property rights on access to medicines. However, it can also be used as a reference for readers who, having already acquired an understanding of the basic concepts in this field, would like to gain a deeper understanding of the issues.

Download Book

Save

Save

Save

Book by the South Centre, 2012

IPR, R&D, Human Rights and Access to Medicines: An Annotated and Selected Bibliography

 

B_IPRRnDHRMedAbout the Book: The South Centre seeks to provide the appropriate technical assistance and country support to developing countries, within a comprehensive and coherent national IP Strategy, to promote the implementation of the TRIPS Agreement that is consistent with the protection of public health and promotion of access to medicines. To this end, the South Centre has prepared this selected and annotated bibliography to assist developing countries to implement IP policies and regulations consistent with development goals and public health principles.

Authors: Germán Velásquez, Carlos Correa and Xavier Seuba

Download Book

Save

Save

Save

Save

Save

Save

Book by the South Centre, 2012

A Guide to Pharmaceutical Patents

 

Bk_2012_A Guide to Pharmaceutical Patents_EN_cover

About The Book: This book examines in detail the purpose and characteristics of the patentability standards and analyses typical claims in pharmaceutical patents. It provides recommendations on ways of implementing such standards in a manner that avoids the grant of patent right on developments which are genuine innovations or which are not properly described.

Editor: Carlos M. Correa is Special Adviser on Trade and Intellectual Property at the South Centre, Geneva.

Download Book

Save

Save

Save

IP Negotiations Monitor 17, April 2016

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: January-March 2016) (more…)

Research Paper 66, March 2016

The Bolar Exception: Legislative Models and Drafting Options

The basic principle of patent law is that once the term of a patent has expired, the protected subject matter becomes a part of the public domain. Hence, it can be freely used, including for commercial purposes, without the interference by the former patent owner. This allows competitors to enter the market immediately after such expiry, eventually leading to lower prices for consumers and welfare gains. (more…)

Research Paper 64, February 2016

Implementing Pro-Competitive Criteria for the Examination of Pharmaceutical Patents

This document discusses criteria for implementing the patentability requirements in relation to patent applications covering products and processes, as well as the use of pharmaceutical products. The adoption of rigorous criteria with this purpose is important for four main reasons. (more…)

IP Negotiations Monitor 16, January 2016

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: October-December 2015) (more…)

IP Negotiations Monitor 15, September 2015

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: July-September 2015) (more…)

SouthViews No. 121, 12 November 2015

The grant of patents and the exorbitant cost of “lifesaving” drugs

By Germán Velásquez

The important relationship between the examination of patents carried out by national patent offices and the right of citizens to access to medicines hasn’t always been well understood. Too often these are viewed as unrelated functions or responsibilities of the state. And the reason is clear: patentability requirements are not defined by patent offices, but frequently by the courts, tribunals, legislation or treaty negotiators. This is the case when patent policy is implemented in isolation from, rather than guided by, public health policy. (more…)

Statement, 6 October 2015

South Centre at the WIPO 2015 Assemblies

The South Centre calls on WIPO Member States to guide the work of the organization towards shaping a more inclusive and balanced international intellectual property system.

(more…)